Abstract:
The Rothberg Institute for Childhood Diseases (TRI), a non-profit research institute devoted to discovering and developing drugs to treat childhood diseases, today announced the release of a new target that may be key to both fighting tuberous sclerosis and cancer. The CommunityTSC project is comprised of 40,000 volunteers and their computers in 93 countries working to identify new drugs to fight TSC and other childhood disorders.